Veradigm PE Ratio 2010-2022 | MDRX
Current and historical p/e ratio for Veradigm (MDRX) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veradigm PE ratio as of July 02, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Veradigm PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-07-02 | 4.70 | 0.00 | |
2022-12-31 | 17.64 | $-0.25 | 0.00 |
2022-09-30 | 15.23 | $0.43 | 35.42 |
2022-06-30 | 14.83 | $0.43 | 34.49 |
2022-03-31 | 22.52 | $1.12 | 20.11 |
2021-12-31 | 18.45 | $1.01 | 18.27 |
2021-09-30 | 13.37 | $5.15 | 2.60 |
2021-06-30 | 18.51 | $5.03 | 3.68 |
2021-03-31 | 15.02 | $4.83 | 3.11 |
2020-12-31 | 14.44 | $4.64 | 3.11 |
2020-09-30 | 8.14 | $-0.30 | 0.00 |
2020-06-30 | 6.77 | $-0.33 | 0.00 |
2020-03-31 | 7.04 | $-1.18 | 0.00 |
2019-12-31 | 9.82 | $-1.09 | 0.00 |
2019-09-30 | 10.98 | $1.17 | 9.38 |
2019-06-30 | 11.63 | $1.00 | 11.63 |
2019-03-31 | 9.54 | $2.26 | 4.22 |
2018-12-31 | 9.64 | $2.08 | 4.63 |
2018-09-30 | 14.25 | $-0.03 | 0.00 |
2018-06-30 | 12.00 | $0.01 | 1200.00 |
2018-03-31 | 12.35 | $-1.20 | 0.00 |
2017-12-31 | 14.55 | $-1.09 | 0.00 |
2017-09-30 | 14.23 | $-1.16 | 0.00 |
2017-06-30 | 12.76 | $-1.06 | 0.00 |
2017-03-31 | 12.68 | $-0.26 | 0.00 |
2016-12-31 | 10.21 | $-0.14 | 0.00 |
2016-09-30 | 13.17 | $-0.01 | 0.00 |
2016-06-30 | 12.70 | $0.02 | 635.00 |
2016-03-31 | 13.21 | $0.06 | 220.17 |
2015-12-31 | 15.38 | $-0.01 | 0.00 |
2015-09-30 | 12.40 | $-0.11 | 0.00 |
2015-06-30 | 13.68 | $-0.23 | 0.00 |
2015-03-31 | 11.96 | $-0.31 | 0.00 |
2014-12-31 | 12.77 | $-0.37 | 0.00 |
2014-09-30 | 13.42 | $-0.48 | 0.00 |
2014-06-30 | 16.05 | $-0.60 | 0.00 |
2014-03-31 | 18.03 | $-0.64 | 0.00 |
2013-12-31 | 15.46 | $-0.59 | 0.00 |
2013-09-30 | 14.87 | $-0.61 | 0.00 |
2013-06-30 | 12.94 | $-0.29 | 0.00 |
2013-03-31 | 13.59 | $-0.12 | 0.00 |
2012-12-31 | 9.42 | $-0.02 | 0.00 |
2012-09-30 | 12.42 | $0.26 | 47.77 |
2012-06-30 | 10.93 | $0.32 | 34.16 |
2012-03-31 | 16.60 | $0.36 | 46.11 |
2011-12-31 | 18.94 | $0.39 | 48.56 |
2011-09-30 | 18.02 | $0.22 | 81.91 |
2011-06-30 | 19.42 | $0.12 | 161.83 |
2011-03-31 | 20.99 | $0.14 | 149.93 |
2010-12-31 | 19.27 | $0.08 | 240.88 |
2010-09-30 | 18.47 | $0.23 | 80.30 |
2010-06-30 | 16.10 | $0.22 | 73.18 |
2010-05-31 | 18.81 | $0.12 | 156.75 |
2010-03-31 | 19.58 | $0.12 | 163.17 |
2010-02-28 | 17.89 | $0.09 | 198.78 |
2009-12-31 | 20.23 | $0.09 | 224.78 |
2009-11-30 | 19.20 | $0.09 | 213.33 |
2009-09-30 | 20.27 | $0.09 | 225.22 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.509B | $0.588B |
Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $46.229B | 58.81 |
Doximity (DOCS) | United States | $10.965B | 50.76 |
Hims & Hers Health (HIMS) | United States | $10.735B | 111.54 |
Tempus AI (TEM) | United States | $10.291B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.659B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.858B | 60.28 |
Hinge Health (HNGE) | United States | $3.535B | 0.00 |
Privia Health (PRVA) | United States | $2.748B | 187.83 |
Enovis (ENOV) | United States | $1.886B | 10.52 |
Phreesia (PHR) | United States | $1.695B | 0.00 |
Schrodinger (SDGR) | United States | $1.512B | 0.00 |
10x Genomics (TXG) | United States | $1.485B | 0.00 |
Azenta (AZTA) | United States | $1.454B | 67.57 |
Omnicell (OMCL) | United States | $1.402B | 24.74 |
Clover Health Investments (CLOV) | United States | $1.400B | 0.00 |
Evolent Health (EVH) | United States | $1.365B | 116.30 |
Claritev (CTEV) | United States | $0.717B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.606B | 0.00 |
Standard BioTools (LAB) | United States | $0.490B | 0.00 |
Butterfly Network (BFLY) | United States | $0.480B | 0.00 |
Talkspace (TALK) | United States | $0.452B | 135.00 |
Outset Medical (OM) | United States | $0.367B | 0.00 |
TruBridge (TBRG) | United States | $0.353B | 782.67 |
Health Catalyst (HCAT) | United States | $0.282B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.257B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.219B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.170B | 0.00 |
American Well (AMWL) | United States | $0.131B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
Pulmonx (LUNG) | United States | $0.108B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
CareCloud (CCLD) | United States | $0.096B | 3.66 |
Insight Molecular Diagnostics (IMDX) | United States | $0.087B | 0.00 |
111 (YI) | China | $0.061B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.050B | 0.00 |
P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
HeartBeam (BEAT) | United States | $0.041B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
Zhongchao (ZCMD) | China | $0.029B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
Precipio (PRPO) | United States | $0.017B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |